Attention Deficit Hyperactivity Disorder and oxidative stress: A short term follow up study

2015 ◽  
Vol 229 (1-2) ◽  
pp. 310-317 ◽  
Author(s):  
Esra Guney ◽  
Fatih Hilmi Cetin ◽  
Murat Alisik ◽  
Huseyin Tunca ◽  
Yasemin Tas Torun ◽  
...  
Keyword(s):  
Oxidative Stress ◽  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Short Term ◽  
Hyperactivity Disorder ◽  
Follow Up Study ◽  
And Oxidative Stress

A Follow-up Study of Relational Processes and Consultation Outcomes for Students with Attention Deficit Hyperactivity Disorder

2009 ◽  
Vol 38 (1) ◽  
pp. 28-37 ◽  
Author(s):  
William P. Erchul ◽  
George J. DuPaul ◽  
Megan S. Bennett ◽  
Priscilla F. Grissom ◽  
Asha K. Jitendra ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Relational Processes ◽  
Hyperactivity Disorder ◽  
Follow Up Study

Attention-deficit/hyperactivity disorder (ADHD) as a risk factor for persistent nocturnal enuresis in children: A two-year follow-up study

2005 ◽  
Vol 94 (11) ◽  
pp. 1619-1625 ◽  
Author(s):  
Dieter Baeyens ◽  
Herbert Roeyers ◽  
Isolde Demeyere ◽  
Sylvie Verté ◽  
Piet Hoebeke ◽  
...  
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Risk Factor ◽  
Attention Deficit ◽  
Nocturnal Enuresis ◽  
Hyperactivity Disorder ◽  
Follow Up Study

Longer term effects of stimulant treatments for Attention-Deficit/Hyperactivity Disorder

2002 ◽  
Vol 6 (1_suppl) ◽  
pp. 45-56 ◽  
Author(s):  
P. Jensen
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Cooperative Group ◽  
First Line ◽  
Short Term ◽  
Hyperactivity Disorder ◽  
Therapeutic Trials ◽  
Behavioral Treatments ◽  
Stimulant Medications

Of pharmacological options available for Attention-Deficit/Hyperactivity Disorder (ADHD), stimulant medications are the most studied, the most commonly used, the most effective, and the first-line choice for treatment. Evidence of the short-term efficacy of methylphenidate (MPH) and other stimulants as well as behavioral treatments in the management of symptoms of ADHD is abundant. This paper reviews therapeutic trials with a duration or follow-up period of 12 months or more and evaluates the longer term outcomes of available treatments for ADHD. The trials were reported by lalongo et al. (1993), Horn et al. (1991), Schachar, Tannock, Cunningham, and Corkum (1997), Gillberg et al. (1997), Hechtman and Abikoff (1995), and the National Institute of Mental Health (MTA Cooperative Group, 1999a, 1999b).

Sign in / Sign up

Export Citation Format

Share Document